Shares of Phreesia, Inc. (NYSE: PHR), a leading healthcare technology company, soared 6.01% intraday on Tuesday, December 10, 2024, following the company's impressive third-quarter fiscal 2025 results and an optimistic outlook for the upcoming fiscal year.
Phreesia reported a 17% year-over-year increase in revenue to $106.8 million for the third quarter ended October 31, 2024. The company also achieved positive adjusted EBITDA of $9.8 million, a significant improvement of $16.4 million compared to the prior year. Encouraged by the strong performance, Phreesia raised its fiscal 2025 adjusted EBITDA guidance to a range of $34 million to $36 million, up from the previous range of $26 million to $31 million.
Looking ahead, the company provided an optimistic outlook for fiscal 2026, expecting revenue to grow by 13% to 15% and adjusted EBITDA to increase by a staggering 129% to 144% compared to fiscal 2025. These positive projections further fueled investor optimism and contributed to the stock's surge.
The solid third-quarter results, raised guidance for the current fiscal year, and robust outlook for fiscal 2026 indicate Phreesia's strong momentum and growth trajectory. Investors responded favorably to the company's impressive performance and upbeat expectations, driving the stock's significant intraday gain.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。